AI for IBD is gradually improving clinical care for gastroenterologists, but it comes with challenges, such as cost and ...

Integrating AI in gastrointestinal endoscopy enhances image analysis, reduces diagnostic variability, and improves patient ...

SPRING HOUSE, PA – Johnson & Johnson (NYSE: JNJ) has submitted a supplemental Biologics License Application (sBLA) to the U.S ...

A study published Nov. 14 in Gastroenterology has found a link between inflammatory bowel disease risk and pesticides, along with other environmental pollutants. Manasi Agrawal, MD, a ...

Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), presents a unique clinical ...

5. The guidance recommends advanced or immunomodulatory therapy after failure of 5-aminosalicylates instead of a "step-up" approach. The recommendations also define moderate to severe disease using a ...

Johnson & Johnson seeks US FDA approval for subcutaneous induction regimen of Tremfya in ulcerative colitis: Spring House, Pennsylvania Monday, November 25, 2024, 11:00 Hrs [IST] ...

Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, are chronic conditions that significantly ... Recent breakthroughs in endoscopic technologies, artificial ...

Notable news about inflammatory bowel disease (IBD) in 2024 included a study evaluating loss of response to tumor necrosis ...

Johnson & Johnson (J&J) Innovation Medicine has submitted a request to the US Food and Drug Administration (FDA) to approve a ...

Inflammatory Bowel Disease is an incurable disease in which diarrhea and bloody excrement of unknown cause continue, and the ...